Parkinsonian Disorders
33
5
9
15
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.0%
1 terminated out of 33 trials
93.8%
+7.2% vs benchmark
6%
2 trials in Phase 3/4
13%
2 of 15 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 15 completed trials
Clinical Trials (33)
Study of Axial and Cognitive Symptoms and Biomarkers of Neurodegeneration in Brain-first and Body-first PD
Slowing Cognitive Decline in Alpha-synucleinopathies by Enhancing Physical Activity
Linac FRACtionated Radiosurgical THALamotomie in Tremors (FRACTHAL)
The National Registry Study For the Real-world Patients With Parkinsonian Disorders in China
Mobile Parkinson Observatory for Worldwide, Evidence-based Research (mPower)
Gait Analysis in Neurological Disease
Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage
Slow-SPEED-NL: Slowing Parkinson's Early Through Exercise Dosage-Netherlands
The Personalized Parkinson Project De Novo Cohort
An Innovative Method in SAliva Samples for the Early Differential Diagnosis of High-impact NeuroDegenerative Diseases Through Raman Spectroscopy
West Sweden Parkinson Objective Measurement Registry Study
Oral Health, Orofacial Function and Oral Health Care in Patients With Parkinson's Disease
Effect of Motor Function, Depression and Sleep Quality on Attention in Parkinson's Disease
External vs Internal-triggered Augmented-reality Visual Cues to Treat Freezing of Gait
Machine Vision Based MDS-UPDRS III Machine Rating
Role and Mechanism of Probiotics in Improving Motor Symptoms in Mild to Moderate Parkinson's Disease
GentleCath Air (Urinary Self-catheterization) - Pain in Female Patients With Neurological Vesico-sphincter Disorders
Intensive Multidisciplinary Rehabilitation and Biomarkers in Parkinson's Disease
Complex Eye Movements in Parkinson's Disease and Related Movement Disorders
Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease